Cardiovascular Innovations Historical Articles |  |
In this section you will find historical articles related to the cardiovascular area. These articles are taken from our sister publication Cardiovascular News.
|
Cardiovascular Innovations Issue 1 |  |
Welcome to the first edition of Cardiovascular Innovations, a newsletter dedicated to bringing you the latest technological developments and most informed opinions in the cardiovascular device world, be they from cardiologists, vascular surgeons, interventional radiologists, related technical disciplines or business people and investors.
|
Cardiovascular Innovations Issue 2 |  |
Welcome to the second issue of Cardiovascular Innovations, a monthly round up of the news and important issues in the cardiovascular device sector. We are taking a broader perspective this issue, looking further afield both timewise and in terms of area.
|
Cardiovascular Innovations Issue 3 |  |
In this third issue we are returning to the cardiovascular field with the commencement of two trials that will assess a new frontier in drug-eluting stents: bifurcated lesions. In addition, we examine how three seperate teams from the United States, the United Kingdom and Russia have addressed the problems of stent design and have come up with three differing solutions.
|
Cardiovascular Innovations Issue 4 |  |
In this fourth issue, we are concentrating on heart valves with a report highlighting developments within the market, new investments in valve products and the latest trial news. In addition, we take a closer look at the Intervascular MRI catheter from TopSpin Medical, which could herald a new era in coronary imaging. We also report the latest developments in stent coatings and the latest DES to hit Europe.
|
Cardiovascular Innovations Issue 5 |  |
In this fifth issue, we are look at Symphony Medical patient enrollment in their Phase II clinical trial of a non-destructive therapy, two new trials from Conor Medsystems, ATS Medical receives CE mark for open pivot mechanical heart valve. The first person in the UK has received a beating heart transplant at Papworth Hospital. Viacor is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 6 |  |
In this sixth issue we look at a new experimental stent innovation from the Netherlands. A new imaging system for patients suffering from peripheral artery disease. The latest advances in nuclear cardiology imaging technologies. Ample Medical is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 7 |  |
This seventh issue contains a wealth of information surrounding stem cell research and tissue engineering. A new concept in treating acute vascular injuries has been created in the form of Vascugel. Tryton Medical is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 8 |  |
This eighth issue highlights many exciting new technologies that are currently entering clinical trials. Such
developments cross the entire cardiovascular and vascular spectrum, from tissue engineering to imaging, and from electrophysiology to stenting. Arizona Heart Innovative Technologies is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 9 |  |
This ninth issue focuses on events from the recent AHA meeting held in Chicago. Also, there is a report on the conflict of interest shadowing TCT. Cappella is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 10 |  |
This tenth issue reviews novel and new approaches to treating atrial fibrillation including: closed-chest, robotic procedure: radiofrequency devices; the Surgifrost XL device and updates from clinical trials. Paracor Medical is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 11 |  |
This eleventh issue reviews how nanomagnets could potentailly enhance medical imaging. This issue also features two breakthrough stories relating to stem cell research. Rafeal Medical Technologies is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 12 |  |
This twelfth issue we announced the creation of a new landmark US trial featuring Edwards Lifesciences' Sapien heart valve system. We also have the latest news regarding the CardioMEMS wireless pressure sensor and the news that Angiotech has begun a trial of its
Vascular Wrap in the US. Tayside Flow Technologies is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 13 |  |
This thirteenth issue we announced that Johnson & Johnson has pulled CoStar DES from the market, Enrolment completed in the SYNTAX clinical trial and Stem cell trials gather pace in US. IDEV Technologies is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 14 |  |
This fourteenth issue reports on a fast track for medical devices in the US and the trial of a hydroxyapatite-coated stent. Cardica is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 15 |  |
This fifteenth issue reports that the CPME and Eucomed have announced a joint declaration of thier intention to establish giudelines on the relationship between the medical profession and the medical technology industry. Jarvik Heart is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 16 |  |
This sixteenth issue reports that Boston Scientific has established two clinical trials on stent technologies. St Jude Medical's first patient is implanted with Trifecta stented tissue heart valve. ev3 and Foxhollow Technologies are to merge. Acorn Cardiovascular is the Company under the Spotlight.
|
Cardiovascular Innovations Issue 17 |  |
This seventeenth issue reports on a landmark study on human embryonic stem cells, the start of enrollment in the STAPLE-2 trial and the completion of ExoSeal trial enrollment. In industry news BioVascular has merged with Revitus and we report on Medtronic's multi-million dollar investment in NanoCor. Product news features FDA approval of the Amplatzer Muscular VSD Occluder and the CE mark for the Sapien Transcatheter Heart Valve.
|
